USANA Health Sciences Inc. (USNA) - 10-K Filing Summary
Business Context and Reporting Period
Company: USANA Health Sciences, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended January 3, 2026 (53-week year).
Business Overview: USANA develops and manufactures nutritional supplements, functional foods, and personal care products. The company operates through two primary reportable segments: Core Nutritional (direct selling model) and Hiya Direct-to-Consumer (acquired in December 2024). The company also maintains an "Other" category including Rise Bar Wellness and Oola Global.
Key Financial Metrics
| Metric | Fiscal 2025 | Fiscal 2024 | Change |
|---|---|---|---|
| Net Sales | $925.3 million | $854.5 million | +8.3% |
| Gross Profit Margin | 78.3% | 81.1% | -280 bps |
| Operating Income | $37.4 million | $66.3 million | -43.6% |
| Net Earnings (Attributable to USANA) | $10.8 million | $42.0 million | -74.4% |
| Diluted EPS | $0.58 | $2.19 | -73.5% |
| Cash and Cash Equivalents | $158.4 million | $181.8 million | -12.9% |
| Operating Cash Flow | $22.3 million | $61.0 million | -63.4% |
| Debt (Line of Credit) | $14.0 million | $23.0 million | -39.1% |
Material Changes vs. Prior Period
- Revenue Growth Driven by Acquisition: Consolidated net sales increased 8.3% primarily due to the inclusion of Hiya Health Products, LLC (acquired Dec 2024), which contributed $130.0 million in incremental sales. This offset a 6.9% decline in the Core Nutritional segment.
- Core Nutritional Decline: The Core Nutritional segment saw a 14.8% decrease in active customers (down to 387,000), driven by declines in Greater China (-15.4%) and Southeast Asia Pacific (-18.2%). Average spend per customer increased 4.4% but was insufficient to offset volume loss.
- Profitability Compression: Net earnings dropped 74.4% due to a combination of lower operating margins and a significant increase in the effective tax rate (from 44.9% to 72.4%). The tax rate increase was driven by lower U.S. earnings before taxes while foreign tax obligations remained relatively stable.
- Impairment Charges: The company recorded a non-cash goodwill impairment charge of $6.5 million and a cost realignment charge of $6.5 million in Q4 2025, primarily related to the Buy-Sell reporting unit and global cost alignment initiatives.
- Margin Impact: Consolidated gross margin decreased 280 basis points, largely attributable to the inclusion of Hiya, which carries lower gross margins relative to the core nutritional business.
Guidance, Outlook, and Risks
- Strategic Focus: Management is prioritizing the integration of Hiya to expand into direct-to-consumer and retail channels. The company is also rolling out an enhanced Brand Partner Compensation Plan to drive growth in the core business.
- China Operations: Greater China remains the largest market (41.3% of net sales) but faces significant regulatory scrutiny regarding direct selling laws. The company operates through a subsidiary, BabyCare, with a business model tailored to local regulations.
- Key Risks:
- Regulatory: Intense scrutiny of direct selling models by the FTC and Chinese regulators; potential changes to compensation plans or business models.
- Customer Base: Continued decline in active customers in core markets; high turnover among Brand Partners.
- Acquisition Integration: Risks associated with integrating Hiya, including failure to achieve synergies or negative reception from existing Brand Partners.
- Tax Structure: Elevated effective tax rate due to geographic misalignment between revenue (mostly foreign) and expenses (mostly U.S.).
- Capital Allocation: The company repurchased $27.5 million of stock in 2025. $34.0 million remains authorized for future repurchases.
Investor Verification Checklist
- Customer Trends: Verify the trajectory of active customer counts in Greater China and the Americas, as these regions drive the majority of core revenue.
- Hiya Integration: Monitor Hiya's subscriber growth and retention rates to assess the success of the acquisition and its contribution to future margins.
- Tax Rate Sustainability: Analyze the drivers of the 72.4% effective tax rate and management's ability to align expenses with revenue geographically to improve after-tax profitability.
- Regulatory Compliance: Review updates on FTC proposed rulemaking regarding earnings claims and Chinese direct selling license renewals for BabyCare.
- Impairment Triggers: Assess the stability of the stock price and market capitalization, which triggered the Q4 goodwill impairment, to gauge future asset valuation risks.